Skip to main content

Hill, Mitch C.'s Form 4 filing

Inari Medical, Inc. (NARI) · filed Sep 14, 2023

Accession no.
0001127602-23-024195
Filed
Sep 14, 2023, 4:41 PM ET
Trade date
Sep 12, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $441.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hill, Mitch C.CIK 0001644989Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 12, 2023Common StockMOption exerciseAcquired+6,500$0.457+$2,970.5178,302Direct
Sep 12, 2023Common StockSSaleDisposed−1,055$66.59−$70,252.45177,247Direct
Sep 12, 2023Common StockSSaleDisposed−2,120$67.70−$143,524175,127Direct
Sep 12, 2023Common StockSSaleDisposed−3,325$68.35−$227,263.75171,802Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 12, 2023Common StockMOption exerciseDisposed−6,500$0.00$0113,977Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)